These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21466653)

  • 1. Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.
    Coto-Llerena M; Pérez-Del-Pulgar S; Crespo G; Carrión JA; Martínez SM; Sánchez-Tapias JM; Martorell J; Navasa M; Forns X
    Am J Transplant; 2011 May; 11(5):1051-7. PubMed ID: 21466653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
    Biggins SW; Trotter J; Gralla J; Burton JR; Bambha KM; Dodge J; Brocato M; Cheng L; McQueen M; Forman L; Chang M; Kam I; Everson G; Spritz RA; Klintmalm G; Rosen HR
    J Hepatol; 2013 May; 58(5):969-76. PubMed ID: 23333445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.
    Sticchi L; Di Biagio A; Rappazzo E; Setti M; De Rosa G; De Hoffer L; Nicolini L; Prinapori R; Bruzzone B
    J Prev Med Hyg; 2013 Jun; 54(2):83-6. PubMed ID: 24396987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL28B polymorphisms of both recipient and donor cooperate to influence IFN treatment response in HCV recurrence after liver transplantation, but IL28B SNPs of the recipient play a major role in IFN-induced blocking of HCV replication.
    Barbera F; Russelli G; Pipitone L; Pietrosi G; Corsale S; Vizzini G; Gridelli B; Conaldi PG
    New Microbiol; 2015 Apr; 38(2):201-10. PubMed ID: 25938745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.
    Chiu KW; Nakano T; Chen KD; Lin CC; Hu TH; Goto S; Chen CL
    PLoS One; 2016; 11(6):e0156846. PubMed ID: 27275739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
    Cisneros E; Baños I; Citores MJ; Duca A; Salas C; Noblejas A; Cañizares M; Millán I; Cuervas-Mons V; Vilches C
    Transplantation; 2012 Aug; 94(3):275-80. PubMed ID: 22790387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
    Allam SR; Krüger B; Mehrotra A; Schiano T; Schröppel B; Murphy B
    PLoS One; 2013; 8(1):e54854. PubMed ID: 23382988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.
    Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A
    World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
    Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
    J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
    Charlton MR; Thompson A; Veldt BJ; Watt K; Tillmann H; Poterucha JJ; Heimbach JK; Goldstein D; McHutchison J
    Hepatology; 2011 Jan; 53(1):317-24. PubMed ID: 21254179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
    Duarte-Rojo A; Veldt BJ; Goldstein DD; Tillman HL; Watt KD; Heimbach JK; McHutchison JG; Poterucha JJ; Vargas-Vorackova F; Charlton MR
    Transplantation; 2012 Jul; 94(2):197-203. PubMed ID: 22766768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
    Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
    Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of donor and recipient single nucleotide polymorphisms of IL28B rs8099917 in living donor liver transplantation for hepatitis C.
    Harada N; Tamura S; Sugawara Y; Togashi J; Ishizawa T; Kaneko J; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Yamashiki N; Kokudo N
    PLoS One; 2014; 9(3):e90462. PubMed ID: 24599320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
    Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
    Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.
    Wong GL; Chan HL; Tse CH; Chan PO; Cheng JC; Cheng JS; Lau SH; Lee EK; Ma JM; Chan AW; Choi PC; Wong VW
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1040-8. PubMed ID: 25639146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
    Kobayashi M; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Chayama K; Miyakawa Y; Kumada H
    J Gastroenterol; 2012 May; 47(5):596-605. PubMed ID: 22438096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.